A case of generalized discoid lupus erythematosus: Successful treatment with imiquimod cream 5%

Advances in Therapy

Volumn 23, Issue 5, 2006, Pages 787-792

  Gül, Ülker ^a   Gönül, Müzeyyen ^a,c   Çakmak, Seray Külcü ^a   Kiliç, Arzu ^a   Demiriz, Murat ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c Baris Mah   (Turkey)

Author keywords

Discoid lupus erythematosus; Imiquimod

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIMALARIAL AGENT; AZATHIOPRINE; DAPSONE; IMIQUIMOD; IMMUNOMODULATING AGENT; RETINOID; STEROID; TACROLIMUS; THALIDOMIDE;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; CREAM; DISCOID LUPUS ERYTHEMATOSUS; DISEASE COURSE; FACE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MALE; SKIN DISEASE; SKIN IRRITATION; SKIN MANIFESTATION; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ADULT; AMINOQUINOLINES; HUMANS; LUPUS ERYTHEMATOSUS, DISCOID; MALE;

EID: 33845623331     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850319     Document Type: Article

References (16)

1. Gerdsen R, Wenzel J, Uerlich M, Bieber T, Petrow W. Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod. Dermatology. 2002;205:416-418.
2. Kuhn A, Becker-Wegerich PM, Ruzicka T, Lehmann P. Successful treatment of discoid lupus erythematosus with argon laser. Dermatology. 2000;201:175-177.
3. Molin L, Tarstedt M. Discoid lupus erythematosus treated with cryotherapy. J Dermatol Treat. 2003;14:182-183.
4. Alfadley A, Rayes HA, Hussein W, Dalan AA, Al-Aboud K. Thalidomide for treatment of severe generalized discoid lupus lesions in two patients with systemic lupus erythematosus. J Am Acad Dermatol. 2003;48:89-91.
5. Carrilo DR, Christensen OB. Treatment of chronic discoid lupus erythematosus with topical tacrolimus. Acta Derm Venereol. 2004;84:233-234.
6. Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol. 2000;43:6-11.
7. Slade HB, Owens ML, Tomai MA, Miller RL. Imiquimod 5% cream (Aldara). Expert Opin Investig Drugs. 1998;7:437-449.
8. Spaner DE, Miller RL, Mena J, Grossman L, Sorrenti V, Shi Y. Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod. Leuk Lymphoma. 1995;46:935-939.
9. McInrurff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol. 2005;125:1-8.
10. Gupta AK, Cherman AM, Tyring SK. Viral and nonviral uses of imiquimod: a review. J Cutan Med Surg. 2005 [Epub ahead of print].
11. Flórez A, Feal C, Torre C, Cruces M. Invasive squamous cell carcinoma treated with imiquimod 5% cream. Acta Derm Venereol. 2004;84:227-255.
12. Harrison S, Sinclair R. Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream. Australas J Dermatol. 2003;44:281-283.
13. Mackenzie-Wood A, Kossard S, Launey J, Wilkinson B, Owens ML. Imiquimod 5% cream in the treatment of Bowen's disease. J Am Acad Dermatol. 2001;44:462-470.
14. Nicolas JF, Thivolet J, Kanitakis J, Lyonnet S. Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a. J Invest Dermatol. 1990;95(6 suppl):142-145.
15. Martinez J, de Misa RF, Boixeda P, Arrazola JM, Ledo A. Long-term results of intralesional interferon alpha-2B in discoid lupus erythematosus. J Dermatol. 1993;20:444-446.
16. Mori M, Pimpinelli N, Romagnoli P, Bernacchi E, Fabbri P, Giannotti B. Dendritic cells in cutaneous lupus erythematosus: a clue to the pathogenesis of lesions. Histopathology. 1994;24:311-321.